Novatek International is pleased to announce that Labatec-Pharma SA in Geneve, Switzerland has chosen Nova-Stability & Nova-LIMS’ Material Management for automating and managing their raw material, finished product and stability process. Both the Nova-Stability and Material Management systems offer powerful functionality and is backed by hundreds of user requirements incorporating the in-depth knowledge of numerous experts in the best quality practices driving higher adoption and greater operational efficiency to our clients.
Novatek International is pleased to welcome Labatec-Pharma to our family of many other prestigious Nova-LIMS clientele such as Hospira, Inc., Merck & Co., Inc., Pfizer, Sanofi-Aventis, Paxvax, Novartis, Medline, Ranbaxy, Biovest International, Inc., Jubilant HollisterStier, Amoun Pharmaceuticals, Virbac USA, and Bayer.
Our services are second to none and our implementation and validation timelines easily beat the industry expectations every time! We invite you to evaluate our applications for yourself and find out why Novatek’s Suite of Quality Management software has become the industry standard. Come see us at booth number 8 at the 1st PDA Europe Annual Meeting in Berlin, Germany this June 28-29, 2016!
About Labatec-Pharma SA:
Labatec Pharma is a fast growing Swiss Pharmaceuticals company based in Geneva Switzerland. We develop, manufacture, market and distribute a wide range of Niche Oral and Injectable products. In 2008, Labatec was acquired by the Founder of Hikma Pharmaceuticals PLC, and remains a privately held company. Labatec headquarters are in Geneva, Switzerland. MENA regional offices were opened in Amman Jordan targeting the Middle East and North Africa (MENA) markets. To learn more about Labatec Pharma, visit them online at: http://www.labatecpharma.com
